header-langage
简体中文
繁體中文
English
Tiếng Việt
한국어
日本語
ภาษาไทย
Türkçe
Scan to Download the APP
Partnered With:

JPMorgan Chase: Raises Moderna's Price Target from $53 to $60

BlockBeats News, July 13th, JPMorgan Chase indicated that it has raised Moderna's (MRNA.O) price target from $53 to $60.

举报 Correction/Report
RelatedRecommended
Clinical Breakthrough Real, but Surge Detached from Fundamentals
This round of sharp decline looks more like a positioning event than an earnings event, with the validation point in Nvidia's guidance.
"Genesis may have lost more money than Genesis has earned since its inception"
Correction/Report
Submit
Add Library
Visible to myself only
Public
Save
Choose Library
Add Library
Cancel
Finish